Diabetic neuropathy after pancreas transplantation: Determinants of recovery

Transplantation

Volumn 63, Issue 6, 1997, Pages 830-838

  Allen, Richard D M ^a   Al Harbi, Ibrahim S ^a   Morris, John G L ^a   Clouston, Paul D ^a   O'Connell, Philip J ^a   Chapman, Jeremy R ^a   Nankivell, Brian J ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NERVE POTENTIAL; PANCREAS TRANSPLANTATION; POLYNEUROPATHY; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; BODY WEIGHT; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGY; FASTING; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HISTOCOMPATIBILITY TESTING; HUMANS; HYPERINSULINISM; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; NEURAL CONDUCTION; NIFEDIPINE; PANCREAS TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0030892254     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703270-00007     Document Type: Article

References (41)

1. Kennedy WR, Navarro X, Sutherland DER. Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 1995; 45: 773.
2. Solders G, Tydén G, Persson A, Groth CG. Improvement of nerve conduction in diabetic neuropathy: a follow-up study 4 year after combined pancreatic and renal transplantation. Diabetes 1992; 41: 946.
3. Brismar T, Tegner R. Experimental uremic neuropathy, part 2. Sodium permeability decrease and inactivation in potential clamped nerve fibers. J Neurol Sci 1984; 65: 37.
4. Dayan AD, Gardener-Thorpe C. Down PF, Gleadle RI. Peripheral neuropathy in uremia: pathological studies on peripheral nerves from 6 patients. Neurology 1970; 20: 649.
5. Morel P, Brayman KL, Kendall DM, et al. Long-term metabolic function of pancreas transplants and influence of rejection episodes. Transplantation 1991; 51: 990.
6. Wilbourn AJ. Diabetic neuropathies. In: Brown WF, Bolton CF, eds. Clinical electromyography. Boston: Butterworth-Heinemann, 1993: 477.
7. Kimura MD. Electrodiagnosis. In: Diseases of nerve and muscle: principles and practice. Philadelphia: F.A. Davis, 1983.
8. Laftavi MR, Chapuis F, Vial C, et al. The impact of pancreas transplantation on diabetic polyneuropathy: one to nine after follow up [Abstract 10.3]. IPITA 1995 Scientific Congress, Miami, FL, June 1995.
9. Robertson S, Cameron NE, Cotter MA. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 1992; 35: 1113.
10. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Br J Pharmacol 1994; 111: 887.
11. Allen RDM, Wilson TG, Grierson JM, et al. Percutaneous biopsy of bladder-drained pancreas transplants. Transplantation 1991; 51: 1213.
12. Odusote K, Ohwororiole A, Roberts O. Electrophysiological quantification of distal polyneuropathy in diabetes. Neurology 1985; 35: 1432.
13. Nankivell BJ, Chapman JR, Bovington K, Spicer ST, O'Connell PJ, Allen RDM. Clinical determinants of glucose homeostasis after pancreas transplantation. Transplantation 1996; 61(12): 1705.
14. Mbanya JCN, Thomas TH, Wilkinson R, Taylor R. Hypertension and hyperinsulinaemia: a relation in diabetes but not hypertension. Lancet 1988; i: 733.
15. Fawdry RM, Grunewald SM, Collins LT, Roberts AJ. Comparative assessment of techniques for investigation of glomerular filtration rate with 99mTc-DTPA. Eur J Nucl Med 1985; 11: 7
16. Remuzzi G, Ruggenenti P, Mauer M. Pancreas and kidney/pancreas transplants: experimental medicine or real improvements? Lancet 1994; 343: 27.
17. Hathaway DK, el-Gebely S, Cardoso SS, Elmer DS, Gaber AO. Autonomie cardiac dysfunction in diabetic transplant recipients succumbing to sudden cardiac death. Transplantation. 1995; 59: 634.
18. Cheung ATW, Perez RV, Basadonna GP, Cox KL, Bry WI. Microangiopathy reversal in successful simultaneous pancreas-kidney transplantation. Transplant Proc 1994; 26: 493.
19. Caldara R, Bandello F, Vigano C, et al. Influence of successful pancreatorenal transplantation on diabetic retinopathy. Transplant Proc 1994; 26: 490.
20. Müller-Felber W, Landgraf R, Scheuler R, et al. Diabetic neuropathy 3 years after sucessful pancreas and kidney transplantation. Diabetes 1993; 42: 1482.
21. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322: 1031.
22. Solders G, Tydén G, Tibell A, Persson A, Groth-CG. Improvement in nerve conduction 8 years after combined pancreatic and renal transplantation. Transplant Proc 1995; 27: 3091.
23. Vial C, Martin X, LefranHois N, Dubernard JM, Chauvin F, Bady B. Sequential electrodiagnostic evaluation of diabetic neuropathy after combined pancreatic and renal transplantation. Diabetologica 1991; 34 (suppl 1): S100.
24. Sugimura K, Dyck PJ. Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy. J Neuro Sci 1982; 53: 501.
25. Malik R, Tesfaye S, Thompson SD, et al. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologica 1993; 36: 454.
26. Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy. Diabetologica 1994; 37: 847.
27. Badmer CW, Masson EA, Savage MW, Benbow S, Patrick AW, Williams G. Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuria. Diabetologia 1994; 34: 1056.
28. Cameron NE, Cotter MA, Robertson S. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 1992; 35: 12.
29. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561.
30. Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present and future. Diabetes 1995; 44: 1355.
31. Daube JR. Electrophysiological testing in neuropathy. In: Dyck PJ, Thomas PK, Ashbury AK, et al., eds. Diabetic neuropathy. Philadephia: W.B. Saunders, 1987: 162.
32. Waxman SG. Functional recovery in diseases of the nervous system. In: Waxman SG, ed. Advances in neurology, Vol 47: Functional recovery in neurological disease. New York: Raven Press, 1988.
33. Thomas PK. Clinical aspects of PNS regeneration. In: Waxman SG, ed. Advances in neurology, Vol 47: Functional recovery in neurological disorders. New York: Raven Press, 1988: 9.
34. Solders G, Persson A, Wilczek H. Autonomic system dysfunction and polyneuropathy in nondiabetic uremia. Transplantation 1986; 41: 616.
35. Ropper AH. Accelerated neuropathy of rena] failure. Arch Neurol 1993; 50: 536.
36. Monnier VM, Sell DR, Nagaraj RH, et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia. Diabetes 1992; 41(suppl 2): 36.
37. Wu JT. Advanced glycosylation end products: a new disease marker for diabetes and aging. J Clin Lab Med 1993; 7: 252.
38. Pittenger GL, Liu D, Vinik AI. The toxic effects of serum from patients with type 1 diabetes mellitus on mouse neuroblastoma cells: a new mechanism for development of diabetic autonomic neuropathy. Diabet Med 1993; 10: 925.
39. Kihara M, Zollman PJ, Smithson IL, Lagerlund TD, Low PA. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. Am J Physiol 1994; 266: E980.
40. White RP, Carrier GO. Enhanced vascular α-adrenergic neuroeffector system in diabetes: importance of calcium. Am J Physiol 1988; 225: H1036.
41. Campbell WW, Ward LC, Swift TR. Nerve conduction velocity varies inversely with height. Muscle Nerve 1981; 4: 520.